GL
Glucose Health, Inc.
GLUC · OTC
$0.43 -4.98% (-$0.02)
1M +22.79%
Market Cap $7.32M
P/E Ratio -
Div. Yield -
ROE 4,212.81%
Bulios Fair Price
$0.28
34.4% downside
Current Price
$0.43
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GLUC is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 99.42x
P/S 25.95x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 36.64%
Rev. growth 31.77%
FCF growth N/A
Profitability
6 /100
Weak Net margin 190.05%
Op. margin 186.70%
FCF margin 60.48%
Quality
13 /100
Poor ROE 4,212.81%
ROA 217.34%
Asset turnover 1.14x
Debt
62 /100
Moderate Current ratio 1.33x
Int. coverage -34.74x
Debt/Equity 0.06x
Stability
51 /100
Moderate Rev. volatility 19.48%
EPS volatility 11.24%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GLUC
Online
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
John Duffy
Employees
3
Headquarters
Bentonville